FULCRUM THERAPEUTICS, INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $197.5M | $58.2M | $25.6M | $35.1M | $35.4M | $57.1M | $96.7M | $72.8M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $357.5M | $249.9M | $242.2M | $207.5M | $226.0M | $119.5M | $100.1M | $74.1M |
| Property, Plant & Equipment | $2.8M | $3.9M | $5.2M | $6.9M | $7.4M | $8.4M | $9.2M | $10.5M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $366.3M | $260.7M | $257.7M | $226.7M | $235.0M | $129.6M | $110.4M | $85.8M |
| Liabilities | ||||||||
| Accounts Payable | $1.6M | $1.2M | $2.8M | $3.6M | $4.8M | $4.1M | $2.2M | $1.3M |
| Total Current Liabilities | $13.0M | $11.0M | $13.7M | $16.7M | $19.2M | $26.7M | $12.1M | $4.2M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $17.3M | $17.7M | $22.5M | $27.7M | $23.5M | $34.4M | $23.3M | $9.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-594.3M | $-519.4M | $-509.7M | $-412.3M | $-302.5M | $-221.6M | $-150.8M | $-68.1M |
| Total Stockholders' Equity | $349.0M | $243.0M | $235.2M | $198.9M | $211.5M | $95.2M | $87.2M | $-63.7M |